Boeing Gets an Upgrade, Moderna Wins FDA Vaccine Approval

Stock Movers

On this episode of Stock Movers:
- Boeing (BA) shares gain after BofA Global Research upgraded the planemaker to buy from neutral, with analyst Ronald Epstein writing that company’s “aircraft emerged as the favored trade tool for the Trump administration in recent trade deals.”
- Moderna (MRNA) shares rise after the drugmaker won FDA approval for its second-generation Covid vaccine for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease.

See omnystudio.com/listener for privacy information.

2025-06-02 3 min Transcript

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.